Status:
COMPLETED
Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of this study is to validate a mathematical modeling of treatment by intermittent hemodialysis using regional citrate anticoagulation with a dialysate containing calcium
Detailed Description
The only visit to the study will be carried out during a usual dialysis session in the intensive care unit of Clermont-Ferrand University Hospital. In addition to the usual care, 2 blood samples will ...
Eligibility Criteria
Inclusion
- Major patient;
- Man or woman ;
- Treated with intermittent hemodialysis for chronic renal failure;
- In whom intermittent hemodialysis with citrate solution for regional anticoagulation is indicated;
- Affiliated with a social security scheme;
- Having given a signed agreement after detailed explanation of the protocol on the basis of the information sheet and likely to comply with it
Exclusion
- Severe hepato-cellular insufficiency (PT \<50%, INR\> 1.5 without anticoagulant);
- Hemoglobin level \<7 g / dL
- Presenting a psychiatric pathology or cognitive impairment rendering him unable to give informed consent;
- Persons under guardianship, curatorship, deprived of liberty or safeguard of justice
- Pregnant or breastfeeding women
- Patient's refusal to participate in the study.
Key Trial Info
Start Date :
February 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04530175
Start Date
February 2 2021
End Date
July 7 2021
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000